Charlotte EmigAssociate Director
Charlotte Emig is an associate director of the Disruptive Health Technology Institute at Carnegie Mellon University.
Prior to her appointment at CMU, Charlotte was Research Program Manager, at the Pittsburgh Tissue Engineering Initiative, the nation's first collaborative organization that included universities and health care institutions working in field of tissue engineering and regenerative medicine. She managed DoD awards for both clinical and basic science research across key institutions from across the Pittsburgh region, including University of Pittsburgh Medical Center (UPMC), Allegheny General, the University of Pittsburgh, Duquesne University, and Carnegie Mellon University.
Charlotte’s previous experience includes 7 years at Stemnion, Inc. where she developed an adult stem cell population for wound healing applications, taking the product from bench through the regulatory process into clinical trials resulting in publications and 9 awarded patents.
Charlotte is a former United States Marine, serving 4 years overseas and awarded among others the National Defense, Navy Achievement Medal, and Certificate of Commendation.
Charlotte is a graduate of the University of Pittsburgh’s Department of Environmental and Occupational Health with a Masters in Molecular Toxicology. She has a Bachelor of Science degree in Animal and Veterinary Science from West Virginia University.